Statute of Limitations
New York: 3 years for personal injury (CPLR § 214). Discovery rule applies. New York also recognizes medical monitoring claims, allowing plaintiffs to seek monitoring costs before a cancer diagnosis is confirmed.
3 years from discovery of injury; medical monitoring available pre-diagnosis
Where to File in New York
Regeneron Pharmaceuticals is headquartered in Tarrytown, NY (Westchester County), within the Southern District of New York. This provides strong personal jurisdiction and makes SDNY a natural venue for Dupixent CTCL cases. The Southern District has extensive experience with complex pharmaceutical MDLs. New York state courts also offer coordination through the NYCAL (New York City Asbestos Litigation) model for mass tort management. New York does not cap compensatory damages in product liability cases. The state's recognition of medical monitoring claims allows at-risk Dupixent users to seek monitoring costs even before a CTCL diagnosis.
Exposure in New York
Source: IQVIA prescription data estimates
Source: Regeneron SEC filings
Source: Memorial Sloan Kettering